✦ LIBER ✦

409 Adalimumab for Ulcerative Colitis Patients Previously Treated With Infliximab: Outcomes at Short and Long Term and Predictors of Response

✍ Scribed by Carlos Taxonera; Jesús Estellés; Ignacio Blanco; Olga Merino; Ignacio Marin-Jimenez; Manuel Barreiro; Cristina Saro; Valle Garcia; Elena Gento; Guillermo Bastida; Javier P. Gisbert; Isabel Vera; Pilar Martínez; Juan L. Mendoza

Book ID: 119431128
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 83 KB
Volume: 138
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(10)60277-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P272 Infliximab for moderate to severe u

P272 Infliximab for moderate to severe ulcerative colitis: Short-and long-term therapy and predictors of response

✍ Y. Ron; H. Yanai; M. Ben Yehoyada; E. Meirovithz; L. Yahav; D. Yeshurun; E. Sant 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 65 KB

Long-term outcome of adalimumab therapy

Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experience

✍ A. OUSSALAH; C. LACLOTTE; J.-B. CHEVAUX; M. BENSENANE; A. BABOURI; A.-A. SERRE; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Efficacy and safety of short-term adalim

Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial

✍ J. HINOJOSA; F. GOMOLLÓN; S. GARCÍA; G. BASTIDA; J. L. CABRIADA; C. SARO; D. CEB 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 557 KB

MAGNA CARTAThe Great CharterPreamble

📂 Fiction 🌐 English ⚖ 11 KB 👁 18 views